A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/24 (2006.01) A61K 9/20 (2006.01) A61K 9/28 (2006.01) A61K 9/32 (2006.01) A61K 9/36 (2006.01)
Patent
CA 2441064
Disclosed in a controlled release sulfonylurea formulation. In certain embodiments, the invention comprises: (a) a core comprising: (i) a sulfonylurea or a pharmaceutically acceptable salt thereof; (ii) a pharmaceutically acceptable polymer; (b) a membrane surrounding the core which is permeable to the sulfonylurea and gastrointestinal fluid, wherein said dosage form provides a mean time to maximum plasma concentration (Tmax) of said sulfonylurea.
L'invention concerne une préparation de sulfonylurée à libération contrôlée. Dans certaines formes de réalisation, l'invention comprend: a) un noyau contenant i) une sulfonylurée ou un sel pharmaceutiquement acceptable de sulfonylurée, ii) un polymère pharmaceutiquement acceptable; b) une membrane entourant le noyau et perméable à la sulfonylurée et aux liquides gastrointestinaux. Cette forme posologique établit une durée moyenne relativement à la teneur maximale en plasma (T¿max?) de la sulfonylurée.
Chen Chih Ming
Chou Joseph
Wong David
Andrx Corporation
Andrx Pharmaceuticals Llc
Gowling Lafleur Henderson Llp
LandOfFree
Controlled release sulfonylurea formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled release sulfonylurea formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release sulfonylurea formulation will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1566773